Kaken Pharmaceutical Co., Ltd.

KKPCF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income$19$8$7$14
Dep. & Amort.$3$3$3$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$3-$6$1-$2
Other Non-Cash$5-$2-$1-$1
Operating Cash Flow$30$3$9$13
Investing Activities
PP&E Inv.-$4-$2-$2-$3
Net Acquisitions-$15$0-$0-$5
Inv. Purchases-$0$0-$0$0
Inv. Sales/Matur.$1$1$0$0
Other Inv. Act.-$0-$5-$0-$0
Investing Cash Flow-$20-$6-$3-$8
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$8$0$0$0
Stock Repurch.-$6$0-$1-$2
Dividends Paid-$7-$6-$6-$6
Other Fin. Act.$0-$0-$0-$0
Financing Cash Flow-$5-$6-$7-$8
Forex Effect$0$0-$0$0
Net Chg. in Cash$5-$9-$0-$3
Supplemental Information
Beg. Cash$65$74$75$77
End Cash$70$65$74$75
Free Cash Flow$25$0$7$10
Kaken Pharmaceutical Co., Ltd. (KKPCF) Financial Statements & Key Stats | AlphaPilot